LifeVantage Posts 13% Revenue Gain in Q4

LifeVantage (NASDAQ:LFVN), a direct selling company specializing in science-driven wellness supplements and nutritional products, released its fiscal 2025 fourth-quarter earnings results on Sept. 4, 2025. The most notable news was a year-over-year revenue increase to $55.1 million in the fourth quarter of fiscal year 2025 and a 21.4% year-over-year increase in adjusted earnings per share (EPS) to $0.17 in the fourth quarter of fiscal year 2025. International sales showed initial signs of growth after a multi-year downturn, yet the Americas region continued to account for the majority of gains.Financial results for fiscal year 2025 largely matched management’s previous guidance ranges, with actual revenue being $228.5 million for fiscal year 2025, at the low end of the $228 million–$235 million range for the full year. While gross margins improved slightly, leaving quarterly profit metrics mixed. The quarter reflected both solid progress and fresh challenges for the business.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool